AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

IMMUNIC, INC. Director's Dealing 2016

Aug 15, 2016

10196_dirs_2016-08-15_9d471f00-a133-4fa4-b3d9-c958e389801a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-08-11

Reporting Person: Hasnain Faheem (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4500	Direct

Footnotes

F1: This amended Form 3 is being filed to correctly report the number of shares directly held by the reporting person.